产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A998498 | Anti-CD28 Reference Antibody (FR104), Anti-CD28 Reference Antibody (FR104), |
|||
A998499 | Anti-CD28L / CD80 Reference Antibody (galiximab), Anti-CD28L / CD80 Reference Antibody (galiximab), |
|||
A998500 | Anti-CD3 Reference Antibody (otelixizumab), Anti-CD3 Reference Antibody (otelixizumab), |
|||
A998501 | Anti-CD3 Reference Antibody (visilizumab), Anti-CD3 Reference Antibody (visilizumab), |
|||
A998502 | Anti-CD34 Reference Antibody (ITRI patent anti-CD34), Anti-CD34 Reference Antibody (ITRI patent anti-CD34), |
|||
A998503 | Anti-CD38 Reference Antibody (daratumumab), Anti-CD38 Reference Antibody (daratumumab), |
|||
A998504 | Anti-CD38 Reference Antibody (felzartamab), Anti-CD38 Reference Antibody (felzartamab), |
|||
A998505 | Anti-CD38 Reference Antibody (isatuximab), Anti-CD38 Reference Antibody (isatuximab), |
|||
A998506 | Anti-CD38 Reference Antibody (mezagitamab), Anti-CD38 Reference Antibody (mezagitamab), |
|||
A998507 | Anti-CD3e Reference Antibody (foralumab), Anti-CD3e Reference Antibody (foralumab), |
|||
A998508 | Anti-CD3e Reference Antibody (teplizumab), Anti-CD3e Reference Antibody (teplizumab), |
|||
A998509 | Anti-CD4 Reference Antibody (ibalizumab), Anti-CD4 Reference Antibody (ibalizumab), |
|||
A998510 | Anti-CD4 Reference Antibody (tregalizumab), Anti-CD4 Reference Antibody (tregalizumab), |
|||
A998511 | Anti-CD4 Reference Antibody (TRX1), Anti-CD4 Reference Antibody (TRX1), |
|||
A998512 | Anti-CD44v6 Reference Antibody (bivatuzumab), Anti-CD44v6 Reference Antibody (bivatuzumab), |
|||
A998513 | Anti-CD46 Reference Antibody (FOR46), Anti-CD46 Reference Antibody (FOR46), |
|||
A998514 | Anti-CD47 Reference Antibody (CC-90002), Anti-CD47 Reference Antibody (CC-90002), |
|||
A998515 | Anti-CD47 Reference Antibody (lemzoparlimab), Anti-CD47 Reference Antibody (lemzoparlimab), |
|||
A998516 | Anti-CD47 Reference Antibody (letaplimab), Anti-CD47 Reference Antibody (letaplimab), |
|||
A998517 | Anti-CD47 Reference Antibody (ligufalimab), Anti-CD47 Reference Antibody (ligufalimab), |